Whalesbook
Socho, Japan ki company Create Medic India mein kya dhamaka karne wali hai! Jo company pehle distributors ke through apna maal bechti thi, woh ab direct market control paane aur local production karne ka plan bana rahi hai. Aur iska sabse bada part hai ₹100 crore ka naya manufacturing plant!
India Mein Seedha Entry
Asal mein, yeh move India ke badhte healthcare sector aur high-tech medical devices ki badhti demand ko pakadne ke liye hai. Global supply chain mein jo problems chal rahi hain, unse bachne aur long-term revenue badhane ka ye ek smart plan hai. Chennai mein ek new subsidiary shuru ho gayi hai April 2026 se, aur ab Chennai, Delhi, Kolkata, Ahmedabad mein direct sales offices khulenge. Yeh sab taaki customers se seedha connect ho saken.
Regional Supply Hub Ka Plan
Is ₹100 crore ke plant ka plan toh sirf India ke liye hi nahi, balki aas-paas ke regions aur Africa ke liye bhi supply hub banane ka hai. Matlab, supply chain ko diversify karne ka bada vision hai!
India Market Rocket Ki Tarah Bhaga
Aur India ka medical device market toh waise bhi rocket ki tarah bhag raha hai! 2025 mein $16.16 billion se 2034 tak $44.76 billion tak ja sakta hai, matlab 12.20% ka CAGR! Sabse achhi baat ye hai ki government bhi 'Make in India' aur PLI scheme se local manufacturing ko boost kar rahi hai. Haan, regulations thode complex hain, jaisa ki Medinippon Healthcare ne CDSCO ke liye help li thi, woh dikhata hai.
Supply Chain Tension Aur Price Hike
Ab aa jao asli problem par – global supply chain. West Asia mein chal rahe conflicts ki wajah se medical devices ke liye jo raw materials hain, especially special plastics, unki prices 50% tak badh gayi hain. Shipping bhi mehngi ho gayi hai aur deliveries mein bhi der ho rahi hai. Create Medic, jo Vietnam, China, aur Japan se products import karti hai, woh bhi isse affected ho rahi hai. Toh yeh local plant unke liye ek safety net banega, jisse baahar ke suppliers par dependance kam hogi aur geopolitical tensions ka asar bhi kam padega.
Company Ka Financial Snapshot
Baat karein company ki financials ki toh April 2026 tak unka market cap around ¥10-11 billion JPY (lagbhag $63.2 million USD) tha. December 2025 tak TTM revenue $90.9 million USD tha, aur P/E ratio lagbhag 14.25x hai. Pichhle ek saal mein market cap 26.68% badha hai aur stock apne 200-day moving average se 13.41% upar chal raha hai.
Aage Kya?
Haan, yeh ₹100 crore ka investment risky toh hai. India ka market competitive hai, regulations change hote rehte hain, aur raw materials ki availability bhi ek issue ho sakti hai. Par agar sab theek raha, toh yeh move Create Medic ko India mein ek strong player bana sakta hai.